




Searching News Database: diabetic nephropathy
HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
HSMN NewsFeed - 10 Apr 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
HSMN NewsFeed - 7 Apr 2008
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
HSMN NewsFeed - 6 Dec 2007
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
HSMN NewsFeed - 17 Jul 2007
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
HSMN NewsFeed - 6 Nov 2006
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
HSMN NewsFeed - 5 Sep 2006
Medior Announces Completion of Series A Financing Round and Appointment of CEO and Chairman
Medior Announces Completion of Series A Financing Round and Appointment of CEO and Chairman
HSMN NewsFeed - 1 Aug 2006
Keryx Biopharmaceuticals Mourns Passing of Board Member Jonathan Spicehandler, MD
Keryx Biopharmaceuticals Mourns Passing of Board Member Jonathan Spicehandler, MD
HSMN NewsFeed - 10 May 2006
NephroGenex Licenses Pyridorin(TM) for Diabetic Nephropathy and Acute Renal Failure
NephroGenex Licenses Pyridorin(TM) for Diabetic Nephropathy and Acute Renal Failure
HSMN NewsFeed - 3 Apr 2006
Pharmacopeia Licenses Novel Therapeutic Candidates From Bristol-Myers Squibb
Pharmacopeia Licenses Novel Therapeutic Candidates From Bristol-Myers Squibb
HSMN NewsFeed - 16 Feb 2006
Keryx Biopharmaceuticals Names Ronald C. Renaud, Jr. as Chief Financial Officer
Keryx Biopharmaceuticals Names Ronald C. Renaud, Jr. as Chief Financial Officer
Additional items found! 21

Members Archive contains
21 additional stories matching:
diabetic nephropathy
(Password required)
diabetic nephropathy
(Password required)